CALLISTO PHARMACEUTICALS INC Net Income
CALLISTO PHARMACEUTICALS INC reported Net Income of -$3.89 million for the 3-month period ending 2012-09-30, per its 10-Q filed 2012-11-19.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2012-11-19
- CALLISTO PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2012-09-30 was -$3.89M.
- CALLISTO PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2012-06-30 was $116.91M.
- CALLISTO PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2012-03-31 was -$3.14M.
- CALLISTO PHARMACEUTICALS INC net income (loss) attributable to parent for the quarter ending 2011-12-31 was -$2.02M.
- CALLISTO PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2011 was -$6.79M.
- CALLISTO PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2010 was -$25.79M.
- CALLISTO PHARMACEUTICALS INC net income (loss) attributable to parent for fiscal 2009 was -$18.36M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 181 month | Net Income (Loss) Attributable to Parent 184 month | Net Income (Loss) Attributable to Parent 187 month | Net Income (Loss) Attributable to Parent 190 month | Net Income (Loss) Attributable to Parent 193 month | Net Income (Loss) Attributable to Parent 196 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | -$3.89M 10-Q · filed 2012-11-19 | $113.02M derived: sum of 2 quarters · filed 2012-11-19 | $109.88M 10-Q · filed 2012-11-19 | $107.86M derived: sum of 4 quarters · filed 2012-11-19 | -$13.39M 10-Q · filed 2012-11-19 | |||||
| 2012-06-30 | $116.91M 10-Q/A · filed 2012-08-28 | $113.77M 10-Q/A · filed 2012-08-28 | $111.75M derived: sum of 3 quarters · filed 2012-08-28 | $111.24M derived: sum of 4 quarters · filed 2012-11-19 | -$9.49M 10-Q/A · filed 2012-08-28 | |||||
| 2012-03-31 | -$3.14M 10-Q · filed 2012-05-15 | -$5.16M derived: sum of 2 quarters · filed 2012-05-15 | -$5.67M derived: sum of 3 quarters · filed 2012-11-19 | -$8.17M derived: sum of 4 quarters · filed 2012-11-19 | -$126.40M 10-Q · filed 2012-05-15 | |||||
| 2011-12-31 | -$2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$2.53M derived: sum of 2 quarters · filed 2012-11-19 | -$5.03M derived: sum of 3 quarters · filed 2012-11-19 | -$6.79M 10-K · filed 2012-03-30 | -$123.26M 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | -$513.32K 10-Q · filed 2012-11-19 | -$3.01M derived: sum of 2 quarters · filed 2012-11-19 | -$4.78M 10-Q · filed 2012-11-19 | -$8.96M derived: sum of 4 quarters · filed 2012-11-19 | -$121.24M 10-Q · filed 2011-11-14 | |||||
| 2011-06-30 | -$2.50M 10-Q/A · filed 2012-08-28 | -$4.26M 10-Q/A · filed 2012-08-28 | -$8.45M derived: sum of 3 quarters · filed 2012-08-28 | -$10.17M derived: sum of 4 quarters · filed 2012-08-28 | -$120.73M 10-Q · filed 2011-08-15 | |||||
| 2011-03-31 | -$1.76M 10-Q · filed 2012-05-15 | -$5.95M derived: sum of 2 quarters · filed 2012-05-15 | -$7.66M derived: sum of 3 quarters · filed 2012-05-15 | -$9.39M derived: sum of 4 quarters · filed 2012-05-15 | ||||||
| 2010-12-31 | -$4.19M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$5.90M derived: sum of 2 quarters · filed 2012-03-30 | -$7.63M derived: sum of 3 quarters · filed 2012-03-30 | -$25.79M 10-K · filed 2012-03-30 | ||||||
| 2010-09-30 | -$1.72M 10-Q · filed 2011-11-14 | -$3.44M derived: sum of 2 quarters · filed 2011-11-14 | -$21.61M 10-Q · filed 2011-11-14 | |||||||
| 2010-06-30 | -$1.72M 10-Q · filed 2011-08-15 | -$19.89M 10-Q · filed 2011-08-15 | ||||||||
| 2009-12-31 | -$18.36M 10-K · filed 2012-03-30 |